Proposed Solutions to Tackle Expensive Medicines in The Netherlands: A Critical Review

December 9, 2021December 9, 2021Netherlands Life Sciences

Read the full article, here

Contributing Advisors

Life Sciences in Netherlands

Hanneke Later-Nijland

Partner,
Genome Lawyers